CURRICULUM VITAE. Website: PalmBeachPain.com. Education: University of Pittsburgh Pittsburgh, PA M.D.

Full text

(1)

Robert J. Friedman, M.D.

Board Certified in Neurology Board Certified in Pain Medicine Board Certified in Neuromuscular Medicine

Certified Independent Medical Examiner

Address: Headache & Pain Center of Palm Beach 1015 W. Indiantown Rd. 7408 Lake Worth Road

Suite 202 Suite 100

Jupiter, FL 33458 Lake Worth, FL 33467 Telephone: (561) 748-0528 E-mail: rjf@palmbeachpain.com Website: PalmBeachPain.com Education: 1982-1986 University of Pittsburgh Pittsburgh, PA M.D. 1978-1982 Dartmouth College Hanover, NH

A.B.; Biology and Psychology; Cum Laude; with distinction in major subject Training:

1986-1987 Intern (Internal Medicine) Allegheny General Hospital Pittsburgh, PA

1987-1990 Neurology Resident Chief Resident

Dartmouth-Hitchcock Medical Center Hanover, NH

5-6/1996 Clinical Fellow

Department of Neurology (Pain Management) John Hopkins University

Baltimore, MD

1999-2000 Interventional Pain Management Training Florida Pain Clinic, Ocala, FL

(2)

1998-Present Robert J. Friedman, M.D. PA / Headache and Pain Center of Palm Beach

Jupiter and Lake Worth, FL 1996-1998 Palm Beach Neurological Group

Palm Beach Gardens and Jupiter, FL 1990-1996 Neurological Consultants, Inc.

Beverly and Gloucester, MA

1983-1984 Tutoring of first-year medical students 1981-1982 Research Assistant

University of California (San Francisco) Department of Neurology-study of pain 1980 Laboratory Assistant and Phlebotomist

New England Deaconess Hospital Boston, MA

Positions Held:

2014-Current Member, Professional Practice Committee, American Association of Neuromuscular & Electrodiagnostic Medicine

2012-Current State Liaison for FL, American Association of Neuromuscular & Electrodiagnostic Medicine

2011-2014 Co-Chair, FL Society of Neurology-FL Society of PM&R EMG/NCS Taskforce 2010-2013 Expert Medical Advisor, FL Division of Workers' Compensation

2000-2004 Lake Worth Surgical Center – Pain Management

2000-2002 Columbia Hospital West Palm Beach-Pain Management 1996-2007 Active / Consulting Staff -Jupiter Medical Center FL

1996-2006 Attending /Courtesy Staff - Palm Beach Gardens Medical Center FL 1999-2000 Consulting Staff- Ocala Regional Hospital, Ocala, FL

1996-1999 Consulting Staff -Savannas Hospital, Port St. Lucie, FL 1990-1996 Active Staff- Beverly Hospital, Beverly, MA

1990-1996 Consulting Staff- Addison Gilbert Hospital, Gloucester, MA 1995-1996 Chairman, Subsection of Neurology, Beverly Hospital 1993-1995 Chairman, Institutional Review Board, Beverly Hospital 1989-1990 Instructor in Clinical Medicine, Dartmouth Medical School Board Certification:

11/1991 Neurology - American Board of Psychiatry and Neurology #34968 11/2000 Pain Medicine – American Board of Psychiatry and Neurology #13 11/2010 Pain Medicine -ABPN - Recertified

9/2008 Neuromuscular Medicine - American Board of Psychiatry and Neurology #67 2/2007 Certified IME- American Board of Independent Medical Examiners

2/2012 Recertified IME- American Board of Independent Medical Examiners 1986 National Board of Medical Examiners

(3)

State Medical Licenses: Florida #ME-0069852

Massachusetts #72897 (previous)

Professional Societies:

American Academy of Pain Medicine

American Association of Neuromuscular & Electrodiagnostic Medicine American Academy of Neurology

Florida Academy of Pain Medicine Florida Society of Neurology Florida Medical Association

Recent Continuing Medical Education:

American Association of Neuromuscular & Electrodiagnostic Medicine 2015 Spring Meeting, Professional Practice Committee Meeting, Chicago, IL May 2, 2015.

Neuromodec, Brain and Spinal Cord Stimulation in Chronic Pain Syndromes, NYC, January 12, 2015

Neuromodec, NYC Neuromodulation Conference 2015 January 9, 2015 - January 11, 2015

American Association of Neuromuscular & Electrodiagnostic Medicine 2014 Annual Meeting, Savannah, GA October 29-November 1, 2014.

American Academy of Pain Medicine 2013 Annual Meeting, Ft. Lauderdale, FL April 11-14th, 2013 American Association of Neuromuscular & Electrodiagnostic Medicine 2012 Annual Meeting, Orlando, FL October 3-6, 2012.

Florida Academy of Pain Medicine 2012 Annual Meeting, Orlando, FL June 22-24, 2012 American Board of Independent Medical Examiners Meeting, Orlando, FL March 8-11, 2012, including AMA Guides to the Evaluation of Permanent Impairment 6th Edition Training Course. Florida Academy of Pain Medicine 2011 Annual Meeting, Palm Beach, FL August 18-21, 2011 Florida Society of Neurology 2010 Annual Meeting, Lake Buena Vista, FL October 1-3, 2010

(4)

Florida Academy of Pain Medicine 2010 Annual Meeting, Palm Beach, FL July 16 – 18, 2010.

Intensive Course in Transcranial Magnetic Stimulation, Berenson-Allen Center for Noninvasive Brain Stimulation, Harvard Medical School, Boston, MA, November 9-13, 2009.

American Association of Neuromuscular & Electrodiagnostic Medicine 2009 Annual Meeting, San Diego-CA, October 7-10, 2009.

American Academy of Pain Medicine 2008 Annual Meeting, Orlando, FL February 13-15, 2008. American Association of Neuromuscular & Electrodiagnostic Medicine 2007 Annual Meeting, Phoenix, AZ, October 7-10, 2007.

Subspecialty Interests:

Headache and Chronic Pain evaluation and treatment Peripheral Nerve Disorders and Neuromuscular Medicine Electromyography and nerve conduction studies

Traumatic Neurological Injuries Brain Stimulation

Neuroimaging Publication:

Alexia without agraphia associated with spleniogeniculate infarction. Neurology 1991 Apr;41(4):587-8 (ISSN: 0028-3878)

Clinical Research Studies (subinvestigator): 1996 Alnitidan-protocol ALN-INT-16, for the Acute Treatment of

Migraine. Janssen Phase III.

Cerestat-Protocol 534.11 for the Treatment of Patients with Ischemic Stroke. Boehringer Ingelheim Phase III.

Lubeluzole-Protocol LUB-INT-13, for the Treatment of Patients with Ischemic Stroke. Janssen Phase III.

Tacrine-Protocol 970-68-22, Treatment of Patients with Dementia of the Alzheimer’s type. Parke Davis.

Milameline-Protocol 979-15 for the Treatment of Patients with Probable Alzheimer’s Disease. Parke Davis

Metrifonate-Protocol X-95-018 in Patients with Probable Alzheimer’s Disease; extension to Protocol D95-018. Parke Davis.

Metrifonate-Protocol U96-001, Long Term Treatment with Metrifonate for Patients with Probable Alzheimer’s Disease. Parke Davis.

UCB L059-Protocol RPCE94AI403 Add on Treatment in Epileptic patients with partial onset seizures. UCB S.A., Phanna sector, Phase III.

Maximum-Protocol 136-043, in the Treatment of acute Migraines, headache pain. Zeneca Pharmaceuticals, Phase III.

MK-462 Protocol 022-00, in the Treatment of Acute Migraine Pain, extension portion. Merke, Phase III.

Rizatriptan-Protocol 046-00, in the Treatment of Migraine Pain. Merke. Phase III.

UCB-L059-Protocol RPCE-94,T-1403, Follow up study on Treatment in Epileptic Patient with Partial onset seizures,

(5)

UCB-SA, Pharma Sector. Phase III.

1997 L-754-030-Protocol 101-00,in the Treatment of Postherpetic

Neuralgia. Merke, Phase IIA.

Rizatriptan/Rapidisc-Protocol 049-00,in the Treatment of Acute Migraine pain. Merke, Phase III.

Gabapentin-Protocol 945-213, in Treatment of Newly diagnosed With Partial Epilepsy. Parke Davis Phase III.

Alniditan S.C.-Protocol ALN-USA-18, in the Treatment of Acute Migraine Attacks. Janssen, Phase III.

Alniditan S.C.-Protocol ALN-17, in the Acute Treatment of Migraine. Janssen Phase III.

LU25-09-Protocol 9G208, in the Treatment of Alzheimer’sDisease. H.Lundbeck A/S, Phase III. Lazabenmide-Protocol PDL-IOOOP, in the Treatment of

Alzheimer’s Disease. Protodigm,Phase III.

Naratriptan-Protocol S2WA4002, for the Treatment of Migraine in subjects who do not respond to Oral Sumatriptan. Glaxo Wellcome, Phase III.

Clomethiazole-Protocol SA-CMZ-0009, in the Treatment of Patients with Acute Ischemic Stroke. Astra, Phase II. Clomethiazole-Protocol SA-CMA-0010, in the Treatment of Patients with Acute Intracerebral Hemorrhage. Astra, Phase II. Clomethiazole-Protocol SA-CMZ-0011, in the Treatment of Patients treated with t-PA for acute Ischemic Stroke.Astra Phase II. Metrifonate-Protocol D97-019 in the Treatment of Alzheimer’s Disease. Bayer, Phase III.

Zydis Selegiline-Protocol Z/SEL/97/025, as in Adjunct in the Management of Parkinsonian patients being treated with Levodopa, M.D.S. Harry, Phase III.

Sertraline-Protocol R-0552, in elderly patients with major Depression. Pfizer, Phase IV.

1998 4991W93-Protocol CIAA2001, in the Acute Treatment of

Migraine Headache. Glaxo Wellcome Phase II.

Pregabalin-Protocol 1008-014-026, for Treatment of painful Diabetic Peripheral Neuropathy. Parke Davis Phase II/III. Idebenone-Protocol PNFP-004, for the Treatment of probable Alzheimer’s Disease. Takeda America Phase III.

Idebenone-added to Treatment with Donepezil-Protocol PNFP- 007, for Patient with probable Alzheimer’s Disease, Takeda America Phase III.

Pregabalin-Protocol 1008-015-026 for the Treatment of Painful Diabetic Neuropathy Parke Davis Phase II/III.

Professional References: Available on request Testimony Experience: Available on request

Figure

Updating...

References

Updating...

Related subjects :